In the late-breaking trials session of the American Heart Association’s Scientific Sessions 2021, which took place in November 2021, six clinical trials in cardiac surgery published their primary results. This review will look into three of them including the management of patients with moderate or less-than-moderate tricuspid regurgitation at the time of surgery for degenerative mitral regurgitation, timing of ticagrelor cessation before coronary artery bypass grafting, and long-term outcomes of ticagrelor-based antiplatelet therapy for secondary prevention of coronary artery bypass grafting.
In 2022, many excellent clinical studies emerged in the field of cardiovascular surgery. Selecting papers published in The New England Journal of Medicine and other top medicine and cardiology journals, this review focused on the research progress on 7 topics in the field of cardiovascular surgery: coronary artery surgery, vascular surgery, valvular surgery, structural heart disease, congenital heart disease, heart transplantation, perioperative management, and special population.
目的 提高胸心血管外科患者ICU轉出交接班質量，避免護理差錯和糾紛。 方法 2010年1月－6月，針對患者轉運出現的問題，在查閱文獻及專家咨詢的情況下，設計制定胸心血管外科ICU患者轉出交接單，對患者轉出ICU時的病情、用藥、并發癥等信息進行完善，同時規范交接班簽字手續。采用調查問卷方式，對交接單運用效果進行評價。 結果 轉出交接單的應用，提高了病房護士對ICU護士交接班質量滿意度，除“醫囑單正確執行”、“簽字和藥物交接班清楚”與運用前滿意程度無差異外，其余條目滿意程度均有所增加，增加率波動在3.7%～33.4%。 結論 轉出交接單使用能夠提高ICU患者術后轉運交接質量，預防護理差錯和糾紛，確保證患者安全。
Facing the increasing cardiovascular disease burden and prevailing population risk factors, the cardiovascular surgery in China was also encountering challenges including imbalances in discipline development, significant divergencies in healthcare quality, lacking of clinical guidelines and domestic critical evidence. The concept of quality control and improvement has been practiced and tested in many disease specialties. Quality improvement programs are urgently needed in China to promote the universal cardiovascular surgery healthcare quality.
The minimally invasive cardiovascular surgery developed rapidly in last decades. In order to promote the development of minimally invasive cardiovascular surgery in China, the Chinese Minimally Invasive Cardiovascular Surgery Committee (CMICS) has gradually standardized the collection and report of the data of Chinese minimally invasive cardiovascular surgery since its establishment. The total operation volume of minimally invasive cardiovascular surgery in China has achieved substantial growth with a remarkable popularization of concepts of minimally invasive medicine in 2019. The data of Chinese minimally invasive cardiovascular surgery in 2019 was reported as a paper for the first time, which may provide reference to cardiovascular surgeons and related professionals.